Last updated: October 13, 2022
Sponsor: Medical University of Vienna
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congenital Heart Disease
Heart Disease
Pentalogy Of Cantrell
Treatment
N/AClinical Study ID
NCT05583656
1888/2018
Ages 5-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- pulmonary valve disease requiring pulmonary valve replacement of their native orprosthetic valve, equal to or greater than five years of age.
- Patients and/or patient´s legal representatives must provide written informed consentas approved and required by the respective institutional review board and agree to itsprovisions.
- The patient has completed all preoperative investigations.
Exclusion
Exclusion Criteria:
- Requires emergency surgery
- Has acute myocardial infarction (MI) within 30 days prior to screening date
- Has MRI or CT scan confirmed stroke, cerebrovascular accident (CVA) or transientischemic attack (TIA) within six months prior to screening date
- Has hemodynamic or respiratory instability requiring inotropic support, mechanicalcirculatory support, or mechanical ventilation within 30 days prior to screening date
- Has active endocarditis/myocarditis or endocarditis/myocarditis within three monthsprior to screening date
- Has renal insufficiency as determined by creatinine level ≥ 2.5 mg/dL within 60 daysprior to screening visit or end-stage renal disease
- Has documented:
- leukopenia (WBC < 3.5x 103/µL),
- acute anemia (Hgb<10.0 g/dL or 6 mmol/L), or
- thrombocytopenia (platelet count < 50x 103/µL) accompanied by history of bleedingdiathesis or coagulopathy within 60 days prior screening date
- Diagnosed with abnormal calcium metabolism and/or hyperparathyroidism 10.Echocardiographic evidence of an intra-cardiac mass, thrombus, or vegetation 11. RVOTaneurysm unless treated during pulmonary valve replacement surgery 12. Has prior organtransplant or is currently an organ transplant candidate 13. Was previously implanted withstudy trial device 14. Previously implanted with an aortic, mitral, or tricuspidbioprosthetic valve or mechanical valve 16. Has presence of non-cardiac disease limitinglife expectancy to less than 12 months 17. Is currently or has recently participated (within six weeks) in another investigational drug or device trial 18. Positive urine orserum pregnancy test in female subjects of child-bearing potential and/or nursing mothers
- Currently incarcerated or unable to give voluntary informed consent 21. Documentedhistory of substance (drug or alcohol) abuse within the last five years prior to screeningdate
Study Design
Total Participants: 40
Study Start date:
August 12, 2019
Estimated Completion Date:
February 01, 2024
Study Description
Connect with a study center
Medical University of Vienna
Vienna, 1090
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.